Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04292405 · ClinicalTrials.gov registry record
Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator
A clinical trial, sponsored by Zoll Medical Corporation.
- Terminated
- Registry status
- 60
- Enrollment target
NCT04292405: Clinical Trial study, sponsored by Zoll Medical Corporation.
NCT04292405 is a clinical trial that was terminated before completion, run by Zoll Medical Corporation. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04292405 was terminated before completion, sponsored by Zoll Medical Corporation.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.
Primary Outcome
Simultaneous CABs recordings from the AUDICOR and WCD devices will be compared
Interventions
- DEVICE Wearable Cardioverter Defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2025-09-30 |
Why NCT04292405 stopped before completion
NCT04292405 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Wearable Cardioverter Defibrillator is the first listed.
NCT04292405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04292405 about?
NCT04292405 is a clinical study titled "Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator". Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.
What is the current status of trial NCT04292405?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2020-01-23. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT04292405?
The interventions under investigation include: Wearable Cardioverter Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT04292405?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI